1. Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin. (19th April 2022) Authors: Penny, Caitlin L.; Quow, Krystina; Rundle, Chandler W.; Al‐Rohil, Rami N.; Cardones, Adela R.; Kheterpal, Meenal K.; Fresco, Amber I. Journal: British journal of dermatology Issue: Volume 187:Number 1(2022) Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin. (1st July 2022) Authors: Penny, Caitlin L.; Quow, Krystina; Rundle, Chandler W.; Al‐Rohil, Rami N.; Cardones, Adela R.; Kheterpal, Meenal K.; Fresco, Amber I. Journal: British journal of dermatology Issue: Volume 187:Number 1(2022) Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Response to 'Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin': reply from the authors. (1st August 2022) Authors: Penny, Caitlin L.; Quow, Krystina; Rundle, Chandler W.; Al‐Rohil, Rami N.; Cardones, Adela R.; Kheterpal, Meenal K.; Fresco, Amber I. Journal: British journal of dermatology Issue: Volume 187:Number 2(2022) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Response to 'Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin': reply from the authors. (24th May 2022) Authors: Penny, Caitlin L.; Quow, Krystina; Rundle, Chandler W.; Al‐Rohil, Rami N.; Cardones, Adela R.; Kheterpal, Meenal K.; Fresco, Amber I. Journal: British journal of dermatology Issue: Volume 187:Number 2(2022) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗